Premium
This is an archive article published on August 26, 2010

Wockhardt tumbles nearly 5

Drug maker Wockhardt today plunged nearly 5 per cent on the BSE...

Drug maker Wockhardt today plunged nearly 5 per cent on the BSE amid media reports that rival Sun Pharmaceutical has opposed the settlement between Wockhardt and some of its creditors.

Reacting to the news,the shares of the pharma major tanked 4.67 per cent to settle at Rs 226.65 on the Bombay Stock Exchange.

In a similar manner,the scrip lost 5.61 per cent to close at Rs 224.70 on the National Stock Exchange. About 18 lakh shares changed hands on both the bourses.

8220;The stock had already seen a huge run up,so there was profit booking in the counter and besides the stock came under pressure due to the negative news,8221; Geojit BNP Paribas Financial Services Assistant Vice-President Gaurang Shah said.

Meanwhile,the broader gauge Sensex ended the day in green at 18,226.35,up 0.26 per cent,from previous close.

According to media reports,Wockhardt is about to enter a deal with various offshore creditors,while Sun Pharma has stepped in opposing the settlement and claimed that it holds about 20 per cent of the foreign currency convertible bonds

FCCBs that Wockhardt had issued to raise USD 110 million.

The opposition by Sun Pharma may delay the new agreement that Wockhardt is planning to enter with FCCBs investors.

Story continues below this ad

Meanwhile,shares of Sun Pharma finished the day at Rs 1,776.40,down 0.36 per cent on the BSE.

 

Latest Comment
Post Comment
Read Comments
Advertisement
Advertisement
Advertisement
Advertisement